DrMolina
@realDrMolina
Did you know Ivermectin is currently part of an active Phase I/II clinical trial for metastatic triple-negative breast cancer? This study is evaluating the side effects and best dose of Ivermectin when combined with balstilimab or pembrolizumab, as well as how effectively the combination can shrink tumors that have spread to other parts of the body.
So next time someone dismisses it as “just a horse dewormer,” you can set the record straight. Study Details | Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer | http://ClinicalTrials.gov